Viking Therapeutics
VKTX
#2115
Rank
ยฃ5.90 B
Marketcap
ยฃ53.01
Share price
-0.54%
Change (1 day)
581.73%
Change (1 year)

Viking Therapeutics (VKTX) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : ยฃ20.46 Million

According to Viking Therapeutics 's latest financial reports the company's total liabilities are ยฃ20.46 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Viking Therapeutics - Total liabilities on balance sheet (from 2014 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31ยฃ15.75 M-17.87%
2022-12-31ยฃ19.18 M194.98%
2021-12-31ยฃ6.5 M-27.09%
2020-12-31ยฃ8.91 M63.88%
2019-12-31ยฃ5.44 M51.44%
2018-12-31ยฃ3.59 M-43.89%
2017-12-31ยฃ6.4 M21.73%
2016-12-31ยฃ5.26 M16.14%
2015-12-31ยฃ4.53 M-71.98%
2014-12-31ยฃ16.16 M6087.71%
2013-12-31ยฃ0.26 M300.62%
2012-12-31ยฃ0.06 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ0.91 B 4,385.70%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.67 B 3,211.51%๐Ÿ‡บ๐Ÿ‡ธ USA